Economics, Policy & Regulation
Pharma Prices Raise Eyebrows
<strong>US: </strong>Heather Bresch, the CEO of Mylan, an American pharmaceuticals company, finds herself at the center of one of the biggest pharma controversies in recent years: price-gouging.